Over Expression of HER2/Neu in Female Ductal Carcinoma: Pure Invasive Versus Invasive with in Situ Component

@inproceedings{AbdelHamid2014OverEO,
  title={Over Expression of HER2/Neu in Female Ductal Carcinoma: Pure Invasive Versus Invasive with in Situ Component},
  author={Mohamed S Abdel-Hamid and Ahmed Mohamed Sadat and Mohamed Salah Abdelbasset and Amr M Mohamed and Hesham y Ahmed Abdel Wahab Nafad and Khald Mohamed Shawky and Solafa Amin Abdelaziz and Lobna Omar El Farouk Abd Elsalam and Mahmoud Ahmed Negida and Reham Shehab El Nemr Esmail and Adel Morad Abdellah and Ahmed Zaki Gharib},
  year={2014}
}
Aims: We are trying to understand the role of HER 2 neu in tumor progression. Study design: Prospective study. Place and duration: Conducted at Bani Swif and Kasr AL Aini university hospitals between May 2013 and May 2014. Methodology: 32 patients were enrolled in the study. The speceimens were obtained surgically .Expression of HER-2-neu receptors done aided with Dako Code No. A0485. Results: In the study there were 15 cases with pure invasive carcinoma and 17 cases with in situ component… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 22 REFERENCES

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.

VIEW 1 EXCERPT

Patterns of chromosomal alterations in breast ductal carcinoma in situ.

VIEW 1 EXCERPT